Skip to main content
Loading…

Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 4 May 2021
  6. Session 6: 13 May 2021 to 8 April 2026
  7. Current session: 14 May 2026 to 16 November 2026
Answer status
Question type

Displaying 146 questions Show Answers

Order by |

Question reference: S7W-05194

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Monday, 16 November 2026
  • Current Status: Answer expected on 1 December 2026

To ask the Scottish Government what consideration it has given to setting clear timescales to phase out animal testing in Scotland's universities.

Question reference: S7W-05110

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government what data it holds, broken down by NHS board, on (a) funding allocated for hybrid closed loop technology, (b) patient uptake of the technology, (c) waiting lists for access to the technology, and (d) staffing levels within diabetes technology services.

Question reference: S7W-05118

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government how many patients are currently receiving disease-modifying therapies for (a) relapsing multiple sclerosis and (b) primary progressive multiple sclerosis in the (i) NHS Forth Valley area and (ii) NHS Lothian area, and, of those patients, what proportion receive their treatments in a (A) hospital setting compared with (B) community or home setting.

Question reference: S7W-05112

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government what plans it has to establish national targets, implementation timelines and performance standards for NHS boards in delivering access to hybrid closed loop technology, following the transfer of funding responsibility to health boards.

Question reference: S7W-05111

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government whether it will publish a transparent and sustainable delivery plan setting out how hybrid closed loop technology access will be funded and supported beyond 2026/27, in line with SIGN 170 guidance.

Question reference: S7W-05119

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government what the average time interval is between ongoing intravitreal injection treatments for patients with (a) wet age-related macular degeneration, (b) diabetic macular oedema and (c) retinal vein occlusion, in the (i) NHS Forth Valley area and (ii) NHS Lothian area.

Question reference: S7W-05121

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government what steps it is taking to shift the diagnosis and treatment of uncomplicated age-related hearing loss from hospital-based care into community-based care.

Question reference: S7W-05083

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government, further to the answer to question S7W-04546 by Jim Fairlie on 9 November 2026, what measurable fish health, welfare and environmental conditions are attached to Marine Fund Scotland awards to salmon farming businesses, how compliance with these conditions is monitored and reported, and under what circumstances funding may be withheld or recovered.

Question reference: S7W-05120

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government what assessment it has made of audiology waiting lists, including the potential impact that delivering more audiology services in the community would have on waiting lists.

Question reference: S7W-05117

  • Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
  • Date lodged: Thursday, 12 November 2026
  • Current Status: Answer expected on 26 November 2026

To ask the Scottish Government what assessment it has made of the recommendations specifically concerning lupus nephritis in The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.